FDA Seeks Input On Inactive Ingredients Database
US Agency Plans To Prioritize Maximum Daily Exposure Information
Industry input is being sought by the FDA on its inactive ingredient database, as the US agency considers how to prioritize the addition of maximum daily exposure limits as well as mulling the removal of specific dosage form information.
